PBE Holdings
Invesco Biotechnology & Genome ETF
1W: -2.2%
1M: -3.7%
3M: +3.4%
YTD: +15.4%
1Y: +32.7%
3Y: +64.8%
5Y: +23.5%
$95.07
-0.03 (-0.03%)
Weekly Expected Move ±2.9%
$90
$92
$95
$98
$101
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$290M
Holdings31
Top 10 Wt48.2%
Beta0.79
% Profitable68%
Coverage100%
Portfolio Valuation
P/E39.5
P/B7.0
P/S6.7
EV/EBITDA26.5
P/FCF21.7
PEG2.42
Profitability & Returns
Gross Margin75.9%
Net Margin12.4%
ROE13.2%
ROA5.5%
ROIC11.0%
Div Yield0.50%
Leverage & Liquidity
Debt/Equity0.89
Debt/Assets0.37
Net Debt/EBITDA1.7x
Interest Cov5.5x
Current Ratio1.91
Quick Ratio1.60
Growth (YoY)
Revenue+14.7%
Net Income+18.6%
EPS+20.0%
FCF+36.4%
EBITDA+9.8%
Rev CAGR 3Y+24.2%
Quality Scores
Piotroski F5.6
Altman Z10.27
IS Quality64.6
IS Overall56.5
IS Value42.3
Median P/E17.8
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 30 | 99.9% | 13.2 |
| Financial Services | 1 | 0.1% | — |
| Other | 3 | 0.0% | — |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 34 of 34 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Natera Inc | NTRA | 6.23% | $26.4M | 63,892 | -301.7 | $58.8B | Healthcare |
| 2 | Illumina Inc | ILMN | 6.17% | $26.2M | 95,618 | 50.5 | $41.3B | Healthcare |
| 3 | Biogen Inc | BIIB | 5.19% | $22.0M | 97,446 | 38.7 | $32.5B | Healthcare |
| 4 | Gilead Sciences Inc | GILD | 5.08% | $21.6M | 144,606 | -55.7 | $179.5B | Healthcare |
| 5 | Amgen Inc | AMGN | 4.84% | $20.5M | 48,646 | 24.8 | $217.5B | Healthcare |
| 6 | Vertex Pharmaceuticals Inc | VRTX | 4.80% | $20.3M | 38,913 | 29.1 | $128.1B | Healthcare |
| 7 | Royalty Pharma PLC | RPRX | 4.77% | $20.2M | 346,593 | 23.7 | $25.3B | Healthcare |
| 8 | Regeneron Pharmaceuticals Inc | REGN | 4.62% | $19.6M | 25,808 | 17.6 | $75.7B | Healthcare |
| 9 | Moderna Inc | MRNA | 3.36% | $14.2M | 73,884 | -23.8 | $75.4B | Healthcare |
| 10 | Novavax Inc | NVAX | 3.17% | $13.4M | 1,243,050 | -6.9 | $1.7B | Healthcare |
| 11 | Repligen Corp | RGEN | 2.93% | $12.4M | 64,585 | 245.5 | $10.3B | Healthcare |
| 12 | Veracyte Inc | VCYT | 2.89% | $12.3M | 266,448 | 31.8 | $3.7B | Healthcare |
| 13 | United Therapeutics Corp | UTHR | 2.89% | $12.3M | 22,631 | 17.9 | $23.0B | Healthcare |
| 14 | Exelixis Inc | EXEL | 2.85% | $12.1M | 206,883 | 17.7 | $14.7B | Healthcare |
| 15 | Halozyme Therapeutics Inc | HALO | 2.80% | $11.9M | 107,340 | 31.2 | $13.0B | Healthcare |
| 16 | TG Therapeutics Inc | TGTX | 2.79% | $11.8M | 211,736 | 17.8 | $8.3B | Healthcare |
| 17 | QIAGEN NV | QGEN | 2.77% | $11.8M | 268,829 | 22.9 | $9.2B | Healthcare |
| 18 | Sarepta Therapeutics Inc | SRPT | 2.67% | $11.3M | 620,211 | -12.2 | $1.8B | Healthcare |
| 19 | Protagonist Therapeutics Inc | PTGX | 2.59% | $11.0M | 77,923 | 115.0 | $9.0B | Healthcare |
| 20 | Incyte Corp | INCY | 2.59% | $11.0M | 90,459 | 14.2 | $23.4B | Healthcare |
| 21 | Legend Biotech Corp | LEGN | 2.58% | $11.0M | 550,910 | -37.1 | $3.4B | Healthcare |
| 22 | Vericel Corp | VCEL | 2.57% | $10.9M | 271,504 | 83.6 | $2.1B | Healthcare |
| 23 | Neurocrine Biosciences Inc | NBIX | 2.56% | $10.9M | 76,511 | 20.3 | $14.4B | Healthcare |
| 24 | BioMarin Pharmaceutical Inc | BMRN | 2.51% | $10.6M | 177,471 | 150.5 | $11.1B | Healthcare |
| 25 | Ardelyx Inc | ARDX | 2.50% | $10.6M | 3,104,336 | -14.8 | $825M | Healthcare |
| 26 | PTC Therapeutics Inc | PTCT | 2.44% | $10.3M | 159,717 | -129.5 | $5.3B | Healthcare |
| 27 | AnaptysBio Inc | ANAB | 2.38% | $10.1M | 201,034 | 7.2 | $1.4B | Healthcare |
| 28 | BioCryst Pharmaceuticals Inc | BCRX | 2.35% | $9.9M | 1,193,733 | -5.7 | $2.1B | Healthcare |
| 29 | Collegium Pharmaceutical Inc | COLL | 2.20% | $9.3M | 427,171 | 14.4 | $714M | Healthcare |
| 30 | ACADIA Pharmaceuticals Inc | ACAD | 1.82% | $7.7M | 383,853 | 8.9 | $3.4B | Healthcare |
| 31 | Invesco Government & Agency Portfolio | AGPXX | 0.08% | $342,045 | 342,045 | — | $79.1B | Financial Services |
| 32 | CASH & EQUIVALENTS Cash | — | 0.00% | $5,728 | 5,728 | — | — | — |
| 33 | USD Pending Dividends Private | — | —% | $761 | — | — | — | — |
| 34 | SECURITIES LENDING - BNYM Private | — | —% | $0 | 1 | — | — | — |